sars-cov-2

  1. rvallee

    COVID-19 neuropathology at Columbia University Irving Medical Center/New York Presbyterian Hospital, 2021, Thakur et al

    (Line breaks mine for legibility) Many patients with SARS-CoV-2 infection develop neurological signs and symptoms, though, to date, little evidence exists that primary infection of the brain is a significant contributing factor. We present the clinical, neuropathological, and molecular findings...
  2. Andy

    The SARS-CoV-2 receptor angiotensin-converting enzyme 2 (ACE2) in [ME/CFS].., 2021, Malato et al

    Full title: The SARS-CoV-2 receptor angiotensin-converting enzyme 2 (ACE2) in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: analysis of high-throughput genetic, epigenetic, and gene expression studies Abstract Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) show...
  3. rvallee

    Functional and microstructural brain abnormalities, fatigue, and cognitive dysfunction after mild COVID-19, 2021, Silva et al

    (Paragraphed for clarity) Although post-acute cognitive dysfunction and neuroimaging abnormalities have been reported after hospital discharge in patients recovered from COVID-19, little is known about persistent, long-term alterations in people without hospitalization. We conducted a...
  4. rvallee

    Persistent neurologic symptoms and cognitive dysfunction in non‐hospitalized Covid‐19 “long haulers”, 2021, Graham et al

    Objective Most SARS‐CoV‐2‐infected individuals never require hospitalization. However, some develop prolonged symptoms. We sought to characterize the spectrum of neurologic manifestations in non‐hospitalized Covid‐19 “long haulers”. Methods This is a prospective study of the first 100...
  5. rvallee

    COVID-19 Survivors' Reports of the Timing, Duration, and Health Impacts of Post-Acute Sequelae of SARS-CoV-2 (PASC) Infection, 2021, Lambert et al

    OBJECTIVE: To evaluate the timing, duration, and health impacts of PASC reported by a large group of primarily non-hospitalized COVID-19 survivors. DESIGN, SETTING, AND PARTICIPANTS: A survey of 5,163 COVID-19 survivors reporting symptoms for more than 21 days following SARS-CoV-2 infection...
  6. rvallee

    Clinical Characteristics, Activity Levels and Mental Health Problems in Children with Long COVID: A Survey of 510 Children, 2021, Buonsenso et al

    Background The World Health Organization has recently recognized Long COVID, calling the international medical community to strengthen research and comprehensive care of patients with this condition. However, if Long COVID pertains to children as well is not yet clear. Methods An anonymous...
  7. Trish

    The biology of coronavirus COVID-19 - including research and treatments

    I have just listened to a very interesting radio program 'BBC Inside Science: Biology of the new coronavirus'. I don't know whether it's available outside the UK. https://www.bbc.co.uk/sounds/play/m000g3gf I suggest we use this thread to share any articles, audio or video of Virologists...
  8. Snow Leopard

    Neuropilin-1 is a host factor for SARS-CoV-2 infection

    Neuropilin-1 is a host factor for SARS-CoV-2 infection James L. Daly, Boris Simonetti, Carlos Antón-Plágaro, Maia Kavanagh Williamson, Deborah K. Shoemark, Lorena Simón-Gracia, Katja Klein, Michael Bauer, Reka Hollandi, Urs F. Greber, Peter Horvath, Richard B. Sessions, Ari Helenius, Julian A...
  9. L

    Antibody for SARS -CoV- 2

    Antibody for SARS -CoV- 2 https://www.biorxiv.org/content/10.1101/2020.03.11.987958v1.full.pdf+html As I remember it an antibody can be used for passive immunisation to reduce deaths in infected individuals. @Jonathan Edwards
Back
Top Bottom